A phase II study of Iressa and vinorelbine/gemcitabine in chemo-naive elderly patients with advanced non-small-cell lung cancer screened for EGFR mutation status.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 05 Aug 2009
At a glance
- Drugs Gefitinib (Primary) ; Gemcitabine; Vinorelbine
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms IVAN
- 05 Aug 2009 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 08 Jun 2009 New trial record.